The forecast for the re-import of sulphonamides to China shows an upward trend from 2024 to 2028, beginning at $873.31K and reaching $931.89K by 2028. This reflects an average annual increase of approximately 1.6% over the five-year forecast period. As of 2023, the re-import value was below the forecast starting point, indicating consistent growth expectations.

Future trends to watch for include:

Economic factors such as changes in China's healthcare policies which could impact demand for sulphonamides.
Global trade dynamics affecting pharmaceutical supply chains.
Technological advancements in drug formulation potentially altering market needs.